Rabies is still responsible for approximately 60,000 human deaths per year mostly in Asia and Africa, and affects especially underserved people. Yet, since the first vaccine developed by Louis Pasteur more than 130 years ago, prophylactic measures have significantly improved. They are now composed of the vaccine allied to purified human or equine rabies immunoglobulins. However, these immunoglobulins are expensive and not easy to reach in developing settings.
Read More

Information gathered from routine visits to the doctor is enough to accurately predict a person’s risk of developing Alzheimer’s disease and related dementias, according to new research led by scientists from Regenstrief Institute, Indiana University and Merck. The researchers developed and tested machine learning algorithms using data from electronic medical records to identify patients who may be at risk for developing the dementia.
Read More

In a surprising study, Oregon State University researchers found that no matter how much stress they placed on mice from either a high-fat diet or strenuous exercise, the animals’ mitochondria were able to adapt and continue their normal processes.
Read More

When it comes to memory, immune cells are known as the “bad cops” of the brain. But new research shows they could also be turned into “good cops” to power memory and learning.
Read More

A team of researchers from the University of California, the University of Zürich, Vanderbilt University and the University of North Carolina at Chapel Hill has found that environmental conditions during childhood can impact the way genes are transcribed, resulting in health issues during adulthood. In their paper published in Proceedings of the National Academy of Sciences, the group describes their study of genetic markers in a database and what they learned from them.
Read More

Blue Water Vaccines Inc., a biopharmaceutical company focused on creating transformative vaccines solving global health challenges, has entered into an exclusive worldwide license agreement for the development of a Streptococcus Pneumoniae vaccine with St. Jude Children’s Research Hospital, the nation’s leading hospital dedicated to understanding, treating and curing childhood cancer and other life-threatening diseases.
Read More

Ziath announces, that as a result of a booth raffle at the recent SLAS 2020 exhibition, that they will be donating $1000 to the KoalaComeback Campaign.
Read More

Ziath has announced the launch of impressiOn – a versatile new semi-automatic device designed to take the strain out of applying friction sealing mats or septum sealing caps to SBS format tube racks.
Read More

The new coronavirus that emerged in central China at the end of last year has killed more than 1,000 people and spread around the world.
Read More

A Griffith University pharmacologist has played a key role in the world-first discovery of an eight-molecule snake venom toxin with the potential to become a diagnostic tool or new drug for neurological and neurodegenerative conditions such as Alzheimer’s, schizophrenia and neuropathic pain.
Read More